Topic Area
Mass Drug Administration
Mass drug administration (MDA) of preventive chemotherapy drugs is the primary tool used to control and eliminate several neglected tropical diseases.Expanding MDA coverage and promoting treatment compliance in communities are essential to interrupting infection transmission and reducing the negative health and social impacts of these diseases.
Selected Content
Annotations correspond to the block of highlighted content to the left.
Please log in to submit an annotation
Quick Facts
MDA is the primary tool used in the control and elimination of five neglected tropical diseases: lymphatic filariasis, onchocerciasis, soil-transmitted helminthiases, schistosomiasis, and trachoma. Between 2015 and 2019, over 1 billion people received treatment for at least one of these diseases each year through MDA programs.
66% of global at-risk population
received treatment through MDA in 2019
81 countries implemented MDA
in 2019, out of the 105 requiring PC through MDA
860 million at-risk individuals in world
are in need of treatment through MDA to prevent LF
Key Facts:
- 66 percent of the of the population requiring preventive chemotherapy, which accounts for 1,156 million people in 81 countries, received treatment by preventive chemotherapy in 2019 for at least one disease.
- Of the 105 endemic countries still requiring preventive chemotherapy, 81 successfully implemented MDA programs in 2019.
- In 2019, 860 million individuals globally were at risk of lymphatic filariasis and in need of preventive chemotherapy through MDA.
MDA 101
Selected Content
Annotations correspond to the block of highlighted content to the left.
Please log in to submit an annotation
Learn More
Explore Mass Drug Administration
Ask an Expert
Our team and partners are available to answer questions that clarify our research, insights, methodology, and conclusions.